These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 20661533)
1. Urothelial cancer stem cells. Dimov I; Visnjic M; Stefanovic V ScientificWorldJournal; 2010 Jul; 10():1400-15. PubMed ID: 20661533 [TBL] [Abstract][Full Text] [Related]
2. Urothelial carcinoma: stem cells on the edge. Brandt WD; Matsui W; Rosenberg JE; He X; Ling S; Schaeffer EM; Berman DM Cancer Metastasis Rev; 2009 Dec; 28(3-4):291-304. PubMed ID: 20012172 [TBL] [Abstract][Full Text] [Related]
3. Bladder cancer stem cells. Tran MN; Goodwin Jinesh G; McConkey DJ; Kamat AM Curr Stem Cell Res Ther; 2010 Dec; 5(4):387-95. PubMed ID: 20955163 [TBL] [Abstract][Full Text] [Related]
4. Normal and neoplastic urothelial stem cells: getting to the root of the problem. Ho PL; Kurtova A; Chan KS Nat Rev Urol; 2012 Oct; 9(10):583-94. PubMed ID: 22890301 [TBL] [Abstract][Full Text] [Related]
5. Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer. Garg M Cancer Metastasis Rev; 2015 Dec; 34(4):691-701. PubMed ID: 26328525 [TBL] [Abstract][Full Text] [Related]
6. Sleeping beauty: awakening urothelium from its slumber. Balsara ZR; Li X Am J Physiol Renal Physiol; 2017 Apr; 312(4):F732-F743. PubMed ID: 28122714 [TBL] [Abstract][Full Text] [Related]
7. [Markers of stem cells and their prognostic values for urothelial carcinomas of the urinary tract]. Osmanov YI; Kogan EA; Rapoport LM; Teodorovich OV; Gaibov JA Urologiia; 2019 Jun; (2):40-49. PubMed ID: 31162900 [TBL] [Abstract][Full Text] [Related]
8. Gemcitabine and mitomycin induced autophagy regulates cancer stem cell pool in urothelial carcinoma cells. Ojha R; Jha V; Singh SK Biochim Biophys Acta; 2016 Feb; 1863(2):347-59. PubMed ID: 26658162 [TBL] [Abstract][Full Text] [Related]
9. Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. He X; Marchionni L; Hansel DE; Yu W; Sood A; Yang J; Parmigiani G; Matsui W; Berman DM Stem Cells; 2009 Jul; 27(7):1487-95. PubMed ID: 19544456 [TBL] [Abstract][Full Text] [Related]
10. The urothelial cell line UROtsa transformed by arsenite and cadmium display basal characteristics associated with muscle invasive urothelial cancers. Hoggarth ZE; Osowski DB; Freeberg BA; Garrett SH; Sens DA; Sens MA; Zhou XD; Zhang KK; Somji S PLoS One; 2018; 13(12):e0207877. PubMed ID: 30550540 [TBL] [Abstract][Full Text] [Related]
11. IMP3 expression in urothelial carcinomas of the urinary bladder. Ozdemir NO; Türk NS; Düzcan E Turk Patoloji Derg; 2011 Jan; 27(1):31-7. PubMed ID: 21469424 [TBL] [Abstract][Full Text] [Related]
12. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449 [TBL] [Abstract][Full Text] [Related]
13. A cell of origin gene signature indicates human bladder cancer has distinct cellular progenitors. Dancik GM; Owens CR; Iczkowski KA; Theodorescu D Stem Cells; 2014 Apr; 32(4):974-82. PubMed ID: 24357085 [TBL] [Abstract][Full Text] [Related]
14. Keratin 6 expression correlates to areas of squamous differentiation in multiple independent isolates of As(+3)-induced bladder cancer. Cao L; Zhou XD; Sens MA; Garrett SH; Zheng Y; Dunlevy JR; Sens DA; Somji S J Appl Toxicol; 2010 Jul; 30(5):416-30. PubMed ID: 20186695 [TBL] [Abstract][Full Text] [Related]
15. Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer. Genitsch V; Kollár A; Vandekerkhove G; Blarer J; Furrer M; Annala M; Herberts C; Pycha A; de Jong JJ; Liu Y; Krentel F; Davicioni E; Gibb EA; Kruithof-de Julio M; Wyatt AW; Seiler R Urol Oncol; 2019 Nov; 37(11):826-836. PubMed ID: 31585777 [TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells in bladder cancer: a revisited and evolving concept. Chan KS; Volkmer JP; Weissman I Curr Opin Urol; 2010 Sep; 20(5):393-7. PubMed ID: 20657288 [TBL] [Abstract][Full Text] [Related]
17. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage. Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643 [TBL] [Abstract][Full Text] [Related]
18. Distinct microRNA alterations characterize high- and low-grade bladder cancer. Catto JW; Miah S; Owen HC; Bryant H; Myers K; Dudziec E; Larré S; Milo M; Rehman I; Rosario DJ; Di Martino E; Knowles MA; Meuth M; Harris AL; Hamdy FC Cancer Res; 2009 Nov; 69(21):8472-81. PubMed ID: 19843843 [TBL] [Abstract][Full Text] [Related]
19. Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells. Yang YM; Chang JW Cancer Invest; 2008 Aug; 26(7):725-33. PubMed ID: 18608209 [TBL] [Abstract][Full Text] [Related]
20. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study]. Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]